Mon, Jul 28, 2014, 8:55 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Synta Pharmaceuticals Corp. (SNTA) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • bosiedude bosiedude Dec 6, 2012 10:41 PM Flag

    Hsp 90 Inhibitor

    Astex Pharmaceuticals has one too...AT13387, but not as far in trials as ganetespib.
    So there you have it, the remaining Hsp90 inhibitors:

    Synta (GANETESPIB)
    Infinity (Retaspimycin, as stated below)
    Vernalis/Novartis (AUY922)
    Astex (AT13387)
    Debiopharm (Debio 0932)

    The others have fallen by the wayside. Vernalis' will crumble due to ocular toxicity. Astex's has shown to be less effective than ganetespib. That leaves Infinity's, Synta's, and maybe Debiopharm's in the game, and we are much farther ahead than theirs. Do your own research. Hsp90 inhibition is the real deal, and we likely have the MOST potent drug with the LEAST side effects.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SNTA
4.02-0.03(-0.74%)Jul 28 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.